Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2008-05-22 |
| Study Made Public: | 2011-04-18 |
Title
Screening of novel antigens for ability to generate broadly neutralising antibodies.
Description
CAVD 295 is a rabbit study assessing several first generation antigens for ability to generate broadly neutralising antibodies.
Sign in to see full information about this study and to download study data.
Products
Saline (non-specific) CFA IFA ZM96 gp140 2F5/4E10 mimotope gp41 Mod gp41 NIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.